A new variant in signal peptide of the human luteinizing hormone receptor (LHCGR) affects receptor biogenesis causing leydig cell hypoplasia

The human luteinizing hormone/chorionic gonadotropin receptor (LHCGR) plays a fundamental role in male and female reproduction. In males, loss-of-function mutations in LHCGR have been associated with distinct degrees of impairment in pre- and postnatal testosterone secretion resulting in a variable...

Full description

Saved in:
Bibliographic Details
Published in:Human molecular genetics 2015-11, Vol.24 (21), p.6003-6012
Main Authors: Vezzoli, Valeria, Duminuco, Paolo, Vottero, Alessandra, Kleinau, Gunnar, Schülein, Ralf, Minari, Roberta, Bassi, Ivan, Bernasconi, Sergio, Persani, Luca, Bonomi, Marco
Format: Article
Language:English
Subjects:
46, XY Disorders of Sex Development - genetics
Animals
Child
Cryptorchidism - genetics
DNA Mutational Analysis
Genital Diseases, Male - genetics
Humans
Hypospadias - genetics
Male
Mutation
Penis - abnormalities
Protein Sorting Signals - genetics
Receptors, LH - biosynthesis
Receptors, LH - genetics
Testis - abnormalities
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The human luteinizing hormone/chorionic gonadotropin receptor (LHCGR) plays a fundamental role in male and female reproduction. In males, loss-of-function mutations in LHCGR have been associated with distinct degrees of impairment in pre- and postnatal testosterone secretion resulting in a variable phenotypic spectrum, classified as Leydig cell hypoplasia (LCH) type 1 (complete LH resistance and disorder of sex differentiation) and type 2 (partial LH resistance with impaired masculinization and fertility). Here, we report the case of an adolescent who came to the pediatric endocrinologist at the age of 12 years old for micropenis and cryptorchidism. Testis biopsy showed profound LCH and absent germinal line elements (Sertoli-only syndrome). The sequence analysis of the LHCGR gene showed the presence of a compound heterozygosity, being one variation, c.1847C>A p.S616Y, already described in association to Hypergonadotropic Hypogonadism, and the other, c.29 C>T p.L10P, a new identified variant in the putative signal peptide (SP) of LHCGR. Functional and structural studies provide first evidence that LHCGR have a functional and cleavable SP required for receptor biogenesis. Moreover, we demonstrate the pathogenic role of the novel p.L10P allelic variant, which has to be considered a loss-of-function mutation significantly contributing, in compound heterozygosity with p.S616Y, to the LCH type 2 observed in our patient.
ISSN:0964-6906
1460-2083
DOI:10.1093/hmg/ddv313